CSTI-300 (SMP-100); a Novel 5-HT3Receptor Partial Agonist with Potential to Treat Patients with Irritable Bowel Syndrome or Carcinoid Syndrome-Reference-Cited by-同舟云学术

CSTI-300 (SMP-100); a Novel 5-HT3Receptor Partial Agonist with Potential to Treat Patients with Irritable Bowel Syndrome or Carcinoid Syndrome

Published:2020-02-26 Issue:1 Volume:373 Page:122-134
ISSN:0022-3565
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:J Pharmacol Exp Ther

Author:

Roberts Alexander,Grafton Gillian,Powell Andrew D.,Brock Kristian,Chen Chunlin,Xie Dejian,Huang Jinkun,Liu Shuang,Cooper Alison J.,Brady Catherine A.,Qureshi Omar,Stamataki Zania,Manning David D.,Moore Nicholas A.,Sargent Bruce J.,Guzzo Peter R.,Barnes Nicholas M.

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference69 articles.

1. The concise guide to PHARMACOLOGY 2015/16: overview;Alexander;Br J Pharmacol,2015

2. Remission of symptoms in carcinoid syndrome with a new 5-hydroxytryptamine M receptor antagonist.

3. Effects of 5-Hydroxytryptamine (Serotonin) Type 3 Antagonists on Symptom Relief and Constipation in Nonconstipated Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

4. The IBS market

5. Altered 5-Hydroxytryptamine Signaling in Patients With Constipation- and Diarrhea-Predominant Irritable Bowel Syndrome

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Structural basis for partial agonism in 5-HT3A receptors;Nature Structural & Molecular Biology;2024-01-04

2. Evaluation of the effectiveness and mechanism of action of the Chang-Kang-Fang formula combined with bifid triple viable capsules on diarrhea-predominant irritable bowel syndrome;Frontiers in Microbiology;2023-06-27

3. Carcinoid Syndrome: Preclinical Models and Future Therapeutic Strategies;International Journal of Molecular Sciences;2023-02-10

4. Potential of natural products in the treatment of irritable bowel syndrome;Phytomedicine;2022-11

5. Tapping into 5-HT3 Receptors to Modify Metabolic and Immune Responses;International Journal of Molecular Sciences;2021-11-02